Navigation Links
CVS/pharmacy Raises Record-breaking $4.4 Million for ALS Research Through Annual ALS Fundraising Campaign
Date:7/25/2008

Check to benefit ALS Therapy Alliance to be presented at Fenway Park

Tonight

WOONSOCKET, R.I., July 25 /PRNewswire/ -- CVS/pharmacy announced today that this year it has raised a record-breaking $4.4 million in just 21 days through its annual in-store fundraising campaign for ALS research. This is the seventh year of the annual fundraising effort which, to date, has raised more than $15 million for ALS research. This year's fundraiser took place in CVS/pharmacy locations nationwide from June 8 - 28.

"We could not be more thrilled with the support from CVS/pharmacy customers for ALS research this year and for the past several years," said Jon Roberts, Senior Vice President and Chief Information Officer of CVS Caremark, who also served as an honorary co-chair of this year's fundraising campaign with Jeanne Bouley, a former CVS employee and ALS patient. "Our CVS/pharmacy customers demonstrated tremendous generosity in recognizing the need for funding for ALS research and we are extremely grateful for their support," Roberts added.

ALS or amyotrophic lateral sclerosis is a disorder in which there is progressive degeneration of motor nerves in the brain and spinal cord leading to paralysis and death, typically within three to five years. There is no known cause or cure for ALS, which affects 25,000 Americans, with 5,000 new cases diagnosed each year.

The CVS/pharmacy funds will be donated to the ALS Therapy Alliance (ATA) which was founded in 2000 to provide a vehicle for a diverse group of scientists and clinicians to coordinate research related to ALS. Scientists involved in the ATA are affiliated with some of the best universities and medical centers, including, Massachusetts General Hospital, Harvard Medical School, Massachusetts Institute of Technology, Harvard University, Brigham and Women's Hospital, Beth Israel Deaconess Hospital, Boston University and the University of Massachusetts. CVS Care
'/>"/>

SOURCE CVS/pharmacy
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Howard University and CVS/pharmacy Announce Ribbon Cutting for the Howard University Pharmacy Practice Laboratory
2. CVS/pharmacy Delivers Disaster Relief in Iowa Communities Impacted by Recent Flooding
3. CVS/pharmacy Makes It Easier for Consumers to Save Money and Track Spending with Health Savings and Flexible Spending Accounts
4. Shining a Light on Sunscreen: Sun Protection Misconceptions Unveiled by Dr. Jeffrey Dover and CVS/pharmacy
5. CVS/pharmacy and CENTURY 21(R) Team Up With Easter Seals Around Chicagoland
6. Practical Gear and Personal Gadgets: CVS/pharmacy Offers a Wide Selection of Affordable Gifts to Delight Dad This Fathers Day
7. Lierac Paris Expands in the United States at Healthy Skincare Centers at CVS/pharmacy
8. CVS/pharmacy and the National Council on Aging Extend Prescription for Better Health Partnership
9. MinuteClinic Hits 500th Clinic Mark; New Locations Open in Dallas, Los Angeles and Orlando CVS/pharmacy Stores
10. Caregivers are Honored as CVS/pharmacy Announces Winners of the For All the Ways You Care Contest
11. Lisa Beth Gerstman Foundation Awarded CVS/pharmacy Community Grant

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)..., WASHINGTON, Nov. 20 T...ators to modify health care reform legislation rel...ding a health insurance individual coverage mandat...eable mandate will minimize adverse selection stem...prescribed by the bill. ,, "The individual mand...
(Date:11/20/2009)... Senators and Congressmen in Competi...their Health Care Vote , ...rs and congressmen running for re-election next ye...guru Charlie Cook, may come to regret voting for H..., according to a breaking Zogby International/ O&r...
(Date:11/20/2009)..., ST. LOUIS, Nov. 20 ... that it will present at the Bank of America Merri...er 2-3, 2009, at the Crowne Plaza Hotel Times Squa...dnesday, December 2nd at 8:30 a.m. Eastern Time. I... live, audio webcast of Centene,s presentation at:...
(Date:11/20/2009)...AS VEGAS, Nov. 20 The f...e Director of the Nevada Health Care Association: ...ommends and thanks Senate Majority Leader Harry Re...closer toward our goal of protecting every Nevada ...re, and preserving the strength and viability of o...
(Date:11/20/2009)...tions of exposure to formaldehyde used for embalmi... increased risk of death from myeloid leukemia, ac...0 in the Journal of the National Cancer Institute...y from lymphohematopoietic malignancies and brain ...dustry workers, all of whom may have worked with f...
Breaking Medicine News(10 mins):Health News:Actuaries to Senate: Strengthen Individual Mandate 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3Health News:Funeral industry workers exposed to formaldehyde face higher risk of leukemia 2
African American youth could experience greater changes in their kidney when they are stressed than white youth. //A study presented at the ISHIB2006 found that lower levels of urine microalbumin and
... who are suffering from cancer are not being given...ar. //The new figures indicate that there is delay...study conducted at 32 hospitals show that people s...hian had actually issued an unconditional apology ...
...it is better to collect and purify urine separatel... sewer, from an environmental// and cost perspecti...y of Technology researcher Jac Wilsenach, who on M...hieved and moreover that raw materials can be recl...
...iversity of California, San Diego (UCSD) School of...cycles of liver cell// death and renewal – liver c...ine the week of June 19 in advance of publication ... The findings by Michael Karin, Ph.D., professor p...
...y's Center for Health Promotion Research, which is... Medicine's Department// of Epidemiology and Bio s...ntract from the Ohio Tobacco Use Prevention and Co...obacco prevention and control efforts supported by...
...Ltd has received approval from the USFDA for manuf...tatin Tablets in the US market. // The compa... the drug in strengths of 80mg with 180 day exclus...nualized market sales for Simvastatin is 4.6 billi...
Other Medicine News:Health News:Increasing Delays In Treatments For Cancer Patients 2Health News:Urine Purification to Revolutionize Waste Water Management 2Health News:Repeated Liver Cell Proliferation, a Cause for Liver Cancer 2Health News:Ohio Tobacco Research and Evaluation Center To Be Developed By Case 2
(Date:11/20/2009)...Newswire-FirstCall/ -- Landauer, Inc. ( LDR) ,...urth quarter and full year of 2009 pre-market on T...ost a conference call for investors on Tuesday, De...rs may access the live call by dialing 877-941-920...9-9835 (international callers), or by visiting the...
(Date:11/20/2009)...ewswire/ -- Reportlinker.com announces that a new ...ue. ,, Pipettes & Pipettors - A Global Mar...om/p0164373/Pipettes--Pipettors---A-Global-Market-...ium=pr&utm_campaign=prnewswire ,, Pipette... any research laboratory. Large-scale applications...
(Date:11/20/2009)... Nov. 20 Boston Scientif... it has received 510(k) clearance from the U.S. Fo...val to market its WallFlex® Fully Covered Eso...ageal strictures (obstructions) caused by tumors i...ageal cancer. ,, (Photo: http://www.newscom....
Breaking Medicine Technology:Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2009 Results 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 3Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 4Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 6Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 7Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 8Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 9Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 10Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 11Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 12Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4Medizone International Inc 28MZEI PK 29 Announces it has Established its Own BSL2A Certified Laboratory Located in Innovation Park Queens Universi 50889 1Medizone International Inc 28MZEI PK 29 Announces it has Established its Own BSL2A Certified Laboratory Located in Innovation Park Queens Universi 50889 2Governor Howard Dean to Appear at A Capella Books Event in Atlanta 50885 1European Prices of 170 Best Selling Drugs Averaged 40 Percent Less Than U S Prices in 2008 50882 1European Prices of 170 Best Selling Drugs Averaged 40 Percent Less Than U S Prices in 2008 50882 2
...uticals,Inc. (Nasdaq: IDIX ), a biopharmaceutical...of drugs for the treatment of human viral and othe...n the company,s HCV,pipeline, including promising ...r compounds for the treatment of hepatitis C. This...t 2:30 p.m. PT at the JP Morgan,Healthcare Confere...
...EGFR Inhibitor-, SOUTH SAN FRANCISCO, Calif., Jan...d that it has initiated a phase 1/2 trial,of XL184...C) who have had,progressive disease while on a reg...cule that simultaneously inhibits the MET, RET and...hase 1 part of the study,safety and pharmacokineti...
Other Medicine Technology:Idenix Pharmaceuticals Provides Update on Hepatitis C Pipeline at JP Morgan Healthcare Conference 2Idenix Pharmaceuticals Provides Update on Hepatitis C Pipeline at JP Morgan Healthcare Conference 3Idenix Pharmaceuticals Provides Update on Hepatitis C Pipeline at JP Morgan Healthcare Conference 4Exelixis Initiates Phase 1/2 Trial of XL184 in Patients With Non-Small Cell Lung Cancer 2Exelixis Initiates Phase 1/2 Trial of XL184 in Patients With Non-Small Cell Lung Cancer 3Exelixis Initiates Phase 1/2 Trial of XL184 in Patients With Non-Small Cell Lung Cancer 4
AOA Near PT Acuity Card - BCAOA
...many common print sizes, from newspaper headline t...ides the examiner a starting point to determine ac...ellow styrene for increased contrast. It features ...ns include Jaeger, M notation, lower case point si...
Spanish Near Point Card
... pages of various contrast levels showing 5 Lea Nu...t levels are 25%, 10%, 5%, 2.5% and 1.25%. These f...ces. These two sets are used for the same test. Ea...inst memorization. Includes instructions. Measures...
Medicine Products: